crohn's disease and glp-1 crohn's glp 1 GLP-1 based therapies and disease course of inflammatory bowel disease-bsmoothhr Relevance of Glucagon-Like Peptide 1

Notably, a clinical study demonstrated that T2DM patients receiving insulin therapy experienced significantly higher rates of pancreatitis compared to those treated with GLP-1RAs, and notably, no pancreatitis cases have been reported in clinical trials of the novel GLP-1RA Cotadutide, indicating that a comprehensive risk assessment of GLP-1RAs for pancreatic cancer remains premature pending additional data on these novel medications [8]

Dehydration from gastrointestinal side effects, as noted in FDA Medication Guides, may contribute substantially to headache development, especially during the initial treatment period when these effects are most pronounced

Our goal is to provide a broader and more nuanced perspective for future research on GLP-1RA-based therapeutics, potentially paving the way for innovative approaches to managing cardiometabolic diseases

Reaching out early makes it easier to adjust your plan and keep your experience smooth

Choline and L-carnitine as precursors of trimethylamine [PMID: 9056994] Laboratory literature summary: Choline and L-carnitine as precursors of trimethylamine